While low-rely MBL almost never progresses to CLL, higher-count MBL progresses to CLL requiring therapy at a price of 1% to two% each year. Significant-depend MBL is distinguished from Rai 0 CLL based upon whether or not the B-mobile rely is earlier mentioned or under five × 109/L. While people today with both of those significant-count MBL and CL